AbbVie, Inc. (ABBV)
216.14
+2.10
(+0.98%)
USD |
NYSE |
Jan 21, 16:00
215.90
-0.24
(-0.11%)
After-Hours: 16:29
AbbVie EPS Diluted (Quarterly): 0.0993 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Amgen, Inc. | 5.934 |
| Biogen, Inc. | 3.171 |
| Gilead Sciences, Inc. | 2.434 |
| Johnson & Johnson | 2.121 |
| Eli Lilly & Co. | 6.211 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 178.00M |
| Revenue (Quarterly) | 15.78B |
| Total Expenses (Quarterly) | 15.60B |
| Enterprise Value | 441.41B |
| Gross Profit Margin (Quarterly) | 66.12% |
| Profit Margin (Quarterly) | 1.13% |
| Earnings Yield | 0.61% |
| Operating Earnings Yield | 4.98% |
| Normalized Earnings Yield | 3.442 |